Handheld Ultrasound-guided Cannulation of Difficult Haemodialysis Arteriovenous Access by Renal Nurses

Sponsor
National Healthcare Group, Singapore (Other)
Overall Status
Completed
CT.gov ID
NCT05410691
Collaborator
(none)
50
1
2
13
3.9

Study Details

Study Description

Brief Summary

Cannulation of complex arteriovenous fistula (AVF) or graft (AVG) is a challenge to renal nurses. Ultrasound (US) guidance on central and peripheral venous access visualisation has been widely adopted in nephrology and shown to reduce complications of vascular interventions. With broader adoption of handheld US devices in clinical services, renal nurses could acquire this point-of-care technique to increase the successful cannulation rate while facilitating confidence build-up during training and practice. We aim to evaluate the use of handheld US on difficult AVF/AVG cannulation in a hospital-based dialysis unit.

Detailed Description

We conducted a prospective randomised controlled study from January 2021 to January 2022. Ten renal nurses were trained by an interventional nephrologist before patient recruitment and had completed a pre- and post-training questionnaire on their confidence level. Fifty haemodialysis patients with complex AVF were randomised to US-guided or conventional cannulation. The total time spent on cannulation and patients' pain scores were also collected.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomised controlled trialRandomised controlled trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Handheld Ultrasound-guided Cannulation of Difficult Haemodialysis Arteriovenous Access by Renal Nurses - A Randomised Controlled Trial
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Jan 31, 2022
Actual Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Conventional

AVF/AVG cannulation by renal nurses in standardised manner

Active Comparator: ultrasound guided

AVF/AVG cannulation by renal nurses by handheld US device

Device: Handheld US device
Handheld US-guided AVF/AVG cannulation

Outcome Measures

Primary Outcome Measures

  1. percentage of successful cannulation [from skin contact to actual start of dialysis]

Secondary Outcome Measures

  1. pre-cannulation assessment time [from patient physical contact to the time before needling thru skin]

    time taken to assess the AVF/AVG with either US or clinical examination before cannulation

  2. cannulation time [skin contact by needle to succesful aspiration of blood from needle]

  3. patients' pain score [needle to skin to end of dialysis session]

    10cm visual analogue scale

  4. complications [from skin contact to actual start of dialysis]

    need for a temporary central venous catheter, single-needle dialysis, or infiltration (e.g. haematoma) that hastened the use of AVF/AVG for the same dialysis session

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. First-time cannulation, 2. Post-angioplasty or thrombectomy, 3. Partial stenosis confirmed with imaging or by vascular surgeons/interventional radiologists, 4. Failed cannulation by dialysis nurses at community centres, 5. Bruises or haematoma around AVF/AVG, 6. Presence of clots in AVF/AVG and 7. Deep-seated access by physical examination.
Exclusion Criteria:

complex access with a high risk of complications (calibre ≤0.4cm or vessels ≥0.8cm in depth from skin)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Allen Liu Singapore Singapore

Sponsors and Collaborators

  • National Healthcare Group, Singapore

Investigators

  • Principal Investigator: Shune Chen, NHG, Khoo Teck Puat Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Allen Liu Yan Lun, Senior Consultant, National Healthcare Group, Singapore
ClinicalTrials.gov Identifier:
NCT05410691
Other Study ID Numbers:
  • AHEG2022
First Posted:
Jun 8, 2022
Last Update Posted:
Jun 8, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Allen Liu Yan Lun, Senior Consultant, National Healthcare Group, Singapore
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 8, 2022